Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations
Journal of Breast Imaging · 2025
DOI: 10.1093/jbi/wbae080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Imaging, 2025. Verfasst von Kathryn Watts Zamora und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Papilloma, Magnetic Resonance Imaging. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Objective
To determine the upgrade rate of exclusively MRI-detected benign papillomas in asymptomatic high-risk patients, patients with a history of cancer, or patients with known malignancy.
Methods
This IRB-approved retrospective study reviewed all breast MRI–guided biopsies yielding papilloma on pathology for all asymptomatic patients undergoing breast MRI for high-risk screening, newly diagnosed breast cancer, or a personal history of breast cancer. All cases were followed by excision or 2-year imaging follow-up. The upgrade rate was determined. Fisher’s exact test was used to determine the significance of associated factors, including lesion type, lesion size, and ipsilateral malignancy.
Results
Of the 258 MRI-guided biopsies, 117 met the inclusion criteria. A 4% (5/117) upgrade rate was found with a 3% (4/117) upgrade rate to ductal carcinoma in situ (DCIS) and a 1% (1/117) upgrade rate to invasive malignancy for all identified papillomas. When evaluating all papillomas, the only associated feature identified to be statically significant for risk of upgrade was ipsilateral malignancy with a 60% (3/5) upgrade rate with a P-value of .0057. When separately evaluating benign papillomas only by excluding those with atypia or additional high-risk lesion at biopsy, a 4% (3/80) upgrade rate to DCIS was found. There was no upgrade to invasive malignancy.
Conclusion
Upgrade of MRI-detected papillomas in asymptomatic high-risk patients, patients with a history of cancer, or patients with known malignancy is 4% in this population, which suggests these lesions may warrant surgical excision.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
ORCID-Profile: Kathryn Watts Zamora, Stefanie Woodard
Zitieren
APA
Zamora, K. W., Yalniz, C., Brar, K., Li, Y., Zalasin, S., & Woodard, S. (2025). Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbae080
Vancouver
Zamora KW, Yalniz C, Brar K, Li Y, Zalasin S, Woodard S. Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations. Journal of Breast Imaging. 2025. doi:10.1093/jbi/wbae080
BibTeX
@article{Zamora2025,
author = {Zamora, Kathryn Watts and Yalniz, Ceren and Brar, Kudratjot and Li, Yufeng and Zalasin, Stefanie and Woodard, Stefanie},
title = {Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations},
journal = {Journal of Breast Imaging},
year = {2025},
doi = {10.1093/jbi/wbae080}
}
EUVIMED